These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8517426)

  • 21. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
    Lacourcière Y; Lefebvre J; Provencher P; Poirier L
    Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisoprolol in the treatment of hypertension in the elderly.
    Broncel M; Chojnowska-Jezierska J; Adamska-Dyniewska H
    J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
    Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
    J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA; McNeil JJ; McGrath BP
    Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ambulatory and clinic blood pressure and heart rate in older persons with isolated systolic hypertension.
    Rutan GH; McDonald RH; Kuller LH
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):880-6. PubMed ID: 1285937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of bisoprolol and nitrendipine on exercise capacity in hypertensive patients with regular physical activity.
    Brion R; Carré F; Verdier JC; Poncelet P; Douard H; Page E; Amoretti R; Gauthier J; Ducardonnet A; Gressin V; Dubanchet A
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):78-83. PubMed ID: 10630736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Bisoprolol and Atenolol on Left Ventricular Mass in Patients with Essential Hypertension.
    Weiss RJ; Rauscher A; Shaw D
    Am J Ther; 1994 Jun; 1(1):81-85. PubMed ID: 11835071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G
    Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
    Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
    Williams B; MacDonald TM; Morant S; Webb DJ; Sever P; McInnes G; Ford I; Cruickshank JK; Caulfield MJ; Salsbury J; Mackenzie I; Padmanabhan S; Brown MJ;
    Lancet; 2015 Nov; 386(10008):2059-2068. PubMed ID: 26414968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
    Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
    Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertension.
    Guha S; Avasthi R; Narain VS; Rajendiran C; Mitra M; Ray S; Majumdar D; Mondal MM; Mani S; Mookerjee S; Saha J; Dastidaro DG
    J Indian Med Assoc; 2013 Dec; 111(12):821-5. PubMed ID: 25154151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, open-label, active-controlled, clinical trial to assess central haemodynamic effects of bisoprolol and atenolol in hypertensive patients.
    Park S; Rhee MY; Lee SY; Park SW; Jeon D; Kim BW; Kwan J; Choi D
    J Hypertens; 2013 Apr; 31(4):813-9. PubMed ID: 23385648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B; Song WH; Liu GZ;
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.